{"ticker": {"uuid": "ae9d8302-e8d3-4a23-9dc7-58eb5854397a", "symbol": "VYNE", "name": "Vyne Therapeutics Inc", "exchange": "NASDAQ", "asset_type": "equity"}, "latest_week": "2026-07-31", "summary": "VYNE closed the latest completed week at 28.56 USD with limited activity-pressure data.", "description": "VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapies for dermatology. The company is headquartered in Bridgewater, New Jersey.", "setup_signature": "Balanced read", "composite_score": "44", "kpis": [{"label": "Latest Close", "value": "28.56 USD", "hint": "2026-07-31"}, {"label": "1W Return", "value": "12.2%", "tone": "positive", "hint": "latest completed week"}, {"label": "4W Return", "value": "-", "tone": "neutral", "hint": "short-term follow-through"}, {"label": "12W Return", "value": "-", "tone": "neutral", "hint": "quarterly tape"}, {"label": "Trend Breadth", "value": "0.0%", "hint": "0 of 2 weeks active"}, {"label": "Volume Ratio", "value": "0.1x", "hint": "vs 13-week average"}], "classification": {"exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "currency": "USD", "market_cap": "22.7M"}, "price": {"trend_line": "-", "fair_value": "27.00 USD", "vs_trend": "-", "vs_fair_value": "5.8%", "high_52": "28.56 USD", "low_52": "23.37 USD", "drawdown": "0.0%", "range_position": "100.0%", "markers": [{"label": "Close", "value": 28.56, "value_label": "28.56", "position": 100, "left": "100.0%", "tone": "neutral"}, {"label": "Trend", "value": null, "value_label": "-", "position": null, "left": "50%", "tone": "positive"}, {"label": "Fair", "value": 27.005, "value_label": "27.00", "position": 70.03853564547205, "left": "70.0%", "tone": "neutral"}], "insights": [{"label": "Range location", "value": "100.0%", "detail": "Shows where the latest close sits between the 52-week low and high.", "tone": "positive"}, {"label": "Trend distance", "value": "-", "detail": "Price premium or discount versus the weekly Trend Line.", "tone": "neutral"}, {"label": "Fair-value gap", "value": "5.8%", "detail": "Premium demand or model discount versus Sharemaestro Fair Value.", "tone": "positive"}, {"label": "High-water gap", "value": "0.0%", "detail": "Distance from the latest 52-week high.", "tone": "neutral"}]}, "momentum": {"returns": [{"label": "1W", "value": 12.220039292730842, "value_label": "12.2%", "tone": "positive", "width": 34.914397979230976}, {"label": "4W", "value": null, "value_label": "-", "tone": "neutral", "width": 0}, {"label": "12W", "value": null, "value_label": "-", "tone": "neutral", "width": 0}, {"label": "26W", "value": null, "value_label": "-", "tone": "neutral", "width": 0}, {"label": "52W", "value": null, "value_label": "-", "tone": "neutral", "width": 0}], "trend_streak": 0, "active_weeks": 0, "active_breadth": "0.0%", "peer": {"scope": "US Healthcare", "count": 955, "rank": 67, "percentile": 93.08176100628931, "avg_weekly_return": -0.5979223914976852}}, "setup": {"scores": [{"label": "Trend", "value": 0, "value_label": "0", "width": 4, "tone": "negative", "description": "Persistence of the active trend backdrop over the last year and current streak."}, {"label": "Momentum", "value": 50.0, "value_label": "50", "width": 50.0, "tone": "neutral", "description": "Blend of 4-week and 12-week follow-through."}, {"label": "Activity Pressure", "value": 50.0, "value_label": "50", "width": 50.0, "tone": "neutral", "description": "Latest activity pressure and whether pressure has improved over four weeks."}, {"label": "Relative Leadership", "value": 50.0, "value_label": "50", "width": 50.0, "tone": "neutral", "description": "Relative leadership and short-term leadership change."}, {"label": "Next-Week Expectancy", "value": 50, "value_label": "50", "width": 50, "tone": "neutral", "description": "Historical one-week follow-through read for the latest completed-week setup state."}, {"label": "Volume", "value": 2.5712963333764436, "value_label": "3", "width": 4, "tone": "negative", "description": "Participation compared with the 13-week volume baseline."}, {"label": "Smart Money", "value": 45.8, "value_label": "46", "width": 45.8, "tone": "neutral", "description": "Activity pressure and recent smart-money signal balance."}, {"label": "Risk Control", "value": 100, "value_label": "100", "width": 100, "tone": "positive", "description": "Drawdown and recent weekly volatility pressure."}], "timeline": [{"week": "24 Jul", "return": null, "return_label": "-", "tone": "neutral", "trend": false, "buy_signal": false, "positive_md": false, "height": 0}, {"week": "31 Jul", "return": 12.220039292730842, "return_label": "12.2%", "tone": "positive", "trend": false, "buy_signal": false, "positive_md": false, "height": 100}]}, "groups": {"sector": {"scope": "US Healthcare", "count": 100, "avg_weekly_return": 0.8361643991386809, "avg_four_week_return": -1.4914500433751068, "avg_twelve_week_return": 9.010961973196158, "trend_breadth": 52.0, "positive_md_breadth": 78.0, "positive_rs_breadth": 49.0, "week_rank": null, "four_week_rank": null, "twelve_week_rank": null, "rank_percentile": null, "current": null, "breadth_bars": [{"label": "Trend", "value": 52.0, "value_label": "52.0%", "tone": "positive", "description": "active weekly trend signals"}, {"label": "MD", "value": 78.0, "value_label": "78.0%", "tone": "positive", "description": "positive activity pressure"}, {"label": "RS", "value": 49.0, "value_label": "49.0%", "tone": "negative", "description": "positive relative leadership"}], "top_peers": [{"id": 3936, "symbol": "THC", "name": "Tenet Healthcare Corporation", "exchange": "NYSE", "url": "/terminal/b546ed3d-f2c6-4bb8-8e4d-94066f779bac/report/", "weekly_return": 9.253859348198977, "weekly_return_label": "9.3%", "weekly_return_tone": "positive", "four_week_return": 25.06381307677204, "four_week_return_label": "25.1%", "four_week_return_tone": "positive", "twelve_week_return": 33.827082676751765, "twelve_week_return_label": "33.8%", "twelve_week_return_tone": "positive", "trend_active": false, "positive_md": true, "positive_rs": true, "four_week_width": 83.54604358924013}, {"id": 5770, "symbol": "DXCM", "name": "DexCom Inc", "exchange": "NASDAQ", "url": "/terminal/ebc374af-f110-4556-9f61-3e092b2c4c12/report/", "weekly_return": 16.64802907464355, "weekly_return_label": "16.6%", "weekly_return_tone": "positive", "four_week_return": 17.122807017543863, "four_week_return_label": "17.1%", "four_week_return_tone": "positive", "twelve_week_return": 37.68355056921301, "twelve_week_return_label": "37.7%", "twelve_week_return_tone": "positive", "trend_active": true, "positive_md": true, "positive_rs": true, "four_week_width": 57.07602339181288}, {"id": 7984, "symbol": "REGN", "name": "Regeneron Pharmaceuticals Inc", "exchange": "NASDAQ", "url": "/terminal/1c42d613-c405-45d7-9f43-f2050c317cb4/report/", "weekly_return": 16.25280102437463, "weekly_return_label": "16.3%", "weekly_return_tone": "positive", "four_week_return": 16.561969828969694, "four_week_return_label": "16.6%", "four_week_return_tone": "positive", "twelve_week_return": 6.832280202410382, "twelve_week_return_label": "6.8%", "twelve_week_return_tone": "positive", "trend_active": false, "positive_md": false, "positive_rs": true, "four_week_width": 55.206566096565645}, {"id": 2166, "symbol": "IQV", "name": "IQVIA Holdings Inc", "exchange": "NYSE", "url": "/terminal/ead67a1d-3331-46b9-962d-63392c114616/report/", "weekly_return": 12.963229992790193, "weekly_return_label": "13.0%", "weekly_return_tone": "positive", "four_week_return": 13.514296754250395, "four_week_return_label": "13.5%", "four_week_return_tone": "positive", "twelve_week_return": 31.509148900453248, "twelve_week_return_label": "31.5%", "twelve_week_return_tone": "positive", "trend_active": false, "positive_md": true, "positive_rs": true, "four_week_width": 45.04765584750132}, {"id": 519, "symbol": "BMY", "name": "Bristol-Myers Squibb Company", "exchange": "NYSE", "url": "/terminal/d302e92e-0d9f-411a-8823-7efba73d07cd/report/", "weekly_return": 5.186020293122883, "weekly_return_label": "5.2%", "weekly_return_tone": "positive", "four_week_return": 12.351625666609323, "four_week_return_label": "12.4%", "four_week_return_tone": "positive", "twelve_week_return": 17.553090042535107, "twelve_week_return_label": "17.6%", "twelve_week_return_tone": "positive", "trend_active": true, "positive_md": true, "positive_rs": true, "four_week_width": 41.172085555364404}], "laggards": [{"id": 6661, "symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "url": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "weekly_return": -8.452696728558786, "weekly_return_label": "-8.5%", "weekly_return_tone": "negative", "four_week_return": -36.71149144254278, "four_week_return_label": "-36.7%", "four_week_return_tone": "negative", "twelve_week_return": -31.620657773081483, "twelve_week_return_label": "-31.6%", "twelve_week_return_tone": "negative", "trend_active": false, "positive_md": false, "positive_rs": false, "four_week_width": 100}, {"id": 4734, "symbol": "ALNY", "name": "Alnylam Pharmaceuticals Inc", "exchange": "NASDAQ", "url": "/terminal/468f0d07-c13a-49aa-ab99-ace36977a221/report/", "weekly_return": -24.377230746587177, "weekly_return_label": "-24.4%", "weekly_return_tone": "negative", "four_week_return": -34.29247394334675, "four_week_return_label": "-34.3%", "four_week_return_tone": "negative", "twelve_week_return": -30.344009489916964, "twelve_week_return_label": "-30.3%", "twelve_week_return_tone": "negative", "trend_active": false, "positive_md": true, "positive_rs": false, "four_week_width": 100}, {"id": 7203, "symbol": "MRNA", "name": "Moderna Inc", "exchange": "NASDAQ", "url": "/terminal/8525148b-d546-4fd1-85af-bbb689255bd7/report/", "weekly_return": 1.3870908082115776, "weekly_return_label": "1.4%", "weekly_return_tone": "positive", "four_week_return": -31.26880641925778, "four_week_return_label": "-31.3%", "four_week_return_tone": "negative", "twelve_week_return": 0.8647654093836225, "twelve_week_return_label": "0.9%", "twelve_week_return_tone": "positive", "trend_active": true, "positive_md": true, "positive_rs": true, "four_week_width": 100}]}, "industry": {"scope": "US Biotechnology", "count": 100, "avg_weekly_return": -1.735800436145357, "avg_four_week_return": -4.8644891975306805, "avg_twelve_week_return": 11.572909234524579, "trend_breadth": 66.0, "positive_md_breadth": 67.0, "positive_rs_breadth": 63.0, "week_rank": null, "four_week_rank": null, "twelve_week_rank": null, "rank_percentile": null, "current": null, "breadth_bars": [{"label": "Trend", "value": 66.0, "value_label": "66.0%", "tone": "positive", "description": "active weekly trend signals"}, {"label": "MD", "value": 67.0, "value_label": "67.0%", "tone": "positive", "description": "positive activity pressure"}, {"label": "RS", "value": 63.0, "value_label": "63.0%", "tone": "positive", "description": "positive relative leadership"}], "top_peers": [{"id": 5541, "symbol": "CRNX", "name": "Crinetics Pharmaceuticals Inc", "exchange": "NASDAQ", "url": "/terminal/6d6e93de-74e7-4867-9dbf-c398d509205c/report/", "weekly_return": -0.2508061626657207, "weekly_return_label": "-0.3%", "weekly_return_tone": "negative", "four_week_return": 97.77409424579683, "four_week_return_label": "97.8%", "four_week_return_tone": "positive", "twelve_week_return": 122.83884738527216, "twelve_week_return_label": "122.8%", "twelve_week_return_tone": "positive", "trend_active": true, "positive_md": true, "positive_rs": true, "four_week_width": 100}, {"id": 5498, "symbol": "CORT", "name": "Corcept Therapeutics Incorporated", "exchange": "NASDAQ", "url": "/terminal/fa26c959-2087-470a-96c3-db662b81c34d/report/", "weekly_return": 20.060822147651002, "weekly_return_label": "20.1%", "weekly_return_tone": "positive", "four_week_return": 26.91497616672209, "four_week_return_label": "26.9%", "four_week_return_tone": "positive", "twelve_week_return": 118.9938791124713, "twelve_week_return_label": "119.0%", "twelve_week_return_tone": "positive", "trend_active": true, "positive_md": true, "positive_rs": true, "four_week_width": 89.71658722240697}, {"id": 7984, "symbol": "REGN", "name": "Regeneron Pharmaceuticals Inc", "exchange": "NASDAQ", "url": "/terminal/1c42d613-c405-45d7-9f43-f2050c317cb4/report/", "weekly_return": 16.25280102437463, "weekly_return_label": "16.3%", "weekly_return_tone": "positive", "four_week_return": 16.561969828969694, "four_week_return_label": "16.6%", "four_week_return_tone": "positive", "twelve_week_return": 6.832280202410382, "twelve_week_return_label": "6.8%", "twelve_week_return_tone": "positive", "trend_active": false, "positive_md": false, "positive_rs": true, "four_week_width": 55.206566096565645}, {"id": 59119, "symbol": "PBLS", "name": "Parabilis Medicines, Inc. Common Stock", "exchange": "NASDAQ", "url": "/terminal/b3926c1d-254a-448e-886d-48357c03782b/report/", "weekly_return": 8.631713554987199, "weekly_return_label": "8.6%", "weekly_return_tone": "positive", "four_week_return": 14.87491548343475, "four_week_return_label": "14.9%", "four_week_return_tone": "positive", "twelve_week_return": null, "twelve_week_return_label": "-", "twelve_week_return_tone": "neutral", "trend_active": false, "positive_md": false, "positive_rs": false, "four_week_width": 49.583051611449164}, {"id": 8453, "symbol": "SYRE", "name": "Spyre Therapeutics Inc.", "exchange": "NASDAQ", "url": "/terminal/d329d34e-ca40-42d6-8284-9b0651071535/report/", "weekly_return": -3.720748066190147, "weekly_return_label": "-3.7%", "weekly_return_tone": "negative", "four_week_return": 13.505713955904424, "four_week_return_label": "13.5%", "four_week_return_tone": "positive", "twelve_week_return": 31.028049836764605, "twelve_week_return_label": "31.0%", "twelve_week_return_tone": "positive", "trend_active": true, "positive_md": true, "positive_rs": true, "four_week_width": 45.01904651968142}], "laggards": [{"id": 59305, "symbol": "SLBT", "name": "SL Science Holding Limited Ordinary Shares", "exchange": "NASDAQ", "url": "/terminal/e4d578b3-8a6d-4687-a221-589ba6630126/report/", "weekly_return": -15.224358974358976, "weekly_return_label": "-15.2%", "weekly_return_tone": "negative", "four_week_return": -55.84307178631052, "four_week_return_label": "-55.8%", "four_week_return_tone": "negative", "twelve_week_return": null, "twelve_week_return_label": "-", "twelve_week_return_tone": "neutral", "trend_active": false, "positive_md": false, "positive_rs": false, "four_week_width": 100}, {"id": 6904, "symbol": "LEGN", "name": "Legend Biotech\u00a0Corp", "exchange": "NASDAQ", "url": "/terminal/ab5da8d0-97dd-4209-8510-70ad3dac23d5/report/", "weekly_return": -16.51665166516651, "weekly_return_label": "-16.5%", "weekly_return_tone": "negative", "four_week_return": -37.98060849214309, "four_week_return_label": "-38.0%", "four_week_return_tone": "negative", "twelve_week_return": -34.03271692745377, "twelve_week_return_label": "-34.0%", "twelve_week_return_tone": "negative", "trend_active": false, "positive_md": false, "positive_rs": false, "four_week_width": 100}, {"id": 6661, "symbol": "IONS", "name": "Ionis Pharmaceuticals Inc", "exchange": "NASDAQ", "url": "/terminal/5af1f9c4-6052-4fe7-80ab-024b91697514/report/", "weekly_return": -8.452696728558786, "weekly_return_label": "-8.5%", "weekly_return_tone": "negative", "four_week_return": -36.71149144254278, "four_week_return_label": "-36.7%", "four_week_return_tone": "negative", "twelve_week_return": -31.620657773081483, "twelve_week_return_label": "-31.6%", "twelve_week_return_tone": "negative", "trend_active": false, "positive_md": false, "positive_rs": false, "four_week_width": 100}]}}, "dynamics": {"activity_pressure": "-", "activity_pressure_tone": "neutral", "activity_pressure_change_4w": null, "activity_pressure_points": "", "relative_leadership": "-", "relative_leadership_tone": null, "relative_leadership_change_4w": null, "relative_leadership_points": "", "expectancy": "Undecided", "expectancy_probability": "-", "expectancy_score": 50, "expectancy_tone": "neutral", "expectancy_bars": [{"value": null, "value_label": "-", "height": 4, "tone": "neutral"}, {"value": null, "value_label": "-", "height": 4, "tone": "neutral"}], "insights": [{"label": "Pressure", "value": "-", "detail": "Latest activity-pressure read.", "tone": "neutral"}, {"label": "Pressure change", "value": "-", "detail": "Four-week change in activity pressure.", "tone": "neutral"}, {"label": "Leadership", "value": "-", "detail": "Latest relative-leadership reading.", "tone": "neutral"}, {"label": "RS change", "value": "-", "detail": "Four-week change in relative leadership.", "tone": "neutral"}]}, "indicators": {"available": true, "activity_pressure_latest": "-", "activity_pressure_average": "-", "activity_pressure_positive_count": 0, "activity_pressure_bars": [{"value": null, "value_label": "-", "height": 4, "tone": "neutral"}, {"value": null, "value_label": "-", "height": 4, "tone": "neutral"}], "activity_pressure_points": "", "expectancy_points": "", "expectancy_bars": [{"value": null, "value_label": "-", "height": 4, "tone": "neutral"}, {"value": null, "value_label": "-", "height": 4, "tone": "neutral"}], "confirmation": [{"label": "Trend active", "value": "0/2", "detail": "Active trend-backdrop weeks in the latest 12-week window.", "tone": "negative"}, {"label": "Positive pressure", "value": "0/2", "detail": "Weeks with constructive activity pressure in the latest 12-week window.", "tone": "negative"}, {"label": "Positive leadership", "value": "0/2", "detail": "Weeks with positive relative leadership in the latest 12-week window.", "tone": "negative"}, {"label": "Activity pressure", "value": "-", "detail": "Current proprietary activity-pressure read.", "tone": "neutral"}, {"label": "Buy signals", "value": "0", "detail": "Accumulation signal count in the latest 12 weeks.", "tone": "neutral"}, {"label": "Reversal markers", "value": "1", "detail": "1 reversal markers", "tone": "negative"}], "trend_backdrop_weeks": 0, "positive_activity_weeks": 0, "positive_leadership_weeks": 0, "accumulation_signal_count": 0, "window_count": 2, "smart_money": {"support_count": 0, "risk_count": 1, "recent_count": 1, "score": 38, "support_label": "No recent accumulation markers", "risk_label": "1 reversal markers"}}, "volume": {"latest": "93.3K", "average_13": "1.5M", "average_52": "1.5M", "ratio_13": "0.1x", "ratio_52": "0.1x", "confirmation": [{"week": "24 Jul", "return": null, "return_label": "-", "return_tone": "neutral", "volume_height": 100, "volume": "3.0M"}, {"week": "31 Jul", "return": 12.220039292730842, "return_label": "12.2%", "return_tone": "positive", "volume_height": 4, "volume": "93.3K"}], "insights": [{"label": "Participation", "value": "0.1x", "detail": "Latest volume versus the 13-week average.", "tone": "neutral"}, {"label": "Baseline", "value": "1.5M", "detail": "13-week average volume.", "tone": "neutral"}, {"label": "One-year base", "value": "1.5M", "detail": "52-week average volume.", "tone": "neutral"}]}, "risk": {"volatility_13": "-", "volatility_52": "-", "downside_weeks": 0, "upside_weeks": 1, "downside_breadth": "0.0%", "average_gain": "12.2%", "average_loss": "-", "distribution_scale": "13%", "return_callouts": [{"label": "Weeks higher", "value": "1 of 1", "detail": "0 weeks finished lower.", "tone": "positive"}, {"label": "Best week", "value": "+12.2%", "detail": "Week of 31 Jul.", "tone": "positive"}, {"label": "Worst week", "value": "+12.2%", "detail": "Week of 31 Jul.", "tone": "negative"}, {"label": "Latest week", "value": "+12.2%", "detail": "Week of 31 Jul.", "tone": "positive"}], "buckets": [{"label": "Strong gains", "count": 1, "share": 100.0, "share_label": "100.0%", "tone": "positive"}, {"label": "Modest gains", "count": 0, "share": 0.0, "share_label": "0.0%", "tone": "positive"}, {"label": "Flat weeks", "count": 0, "share": 0.0, "share_label": "0.0%", "tone": "neutral"}, {"label": "Modest losses", "count": 0, "share": 0.0, "share_label": "0.0%", "tone": "negative"}, {"label": "Sharp losses", "count": 0, "share": 0.0, "share_label": "0.0%", "tone": "negative"}], "insights": [{"label": "Recent vol", "value": "-", "detail": "13-week weekly-return volatility.", "tone": "neutral"}, {"label": "Base vol", "value": "-", "detail": "52-week weekly-return volatility.", "tone": "neutral"}, {"label": "Up/down split", "value": "1/0", "detail": "Count of positive and negative weeks in the 52-week window.", "tone": "positive"}, {"label": "Average skew", "value": "12.2% / -", "detail": "Average positive week versus average negative week.", "tone": "neutral"}]}, "signals": [{"label": "Trend backdrop", "value": "Inactive", "tone": "negative"}, {"label": "Activity pressure", "value": "No fresh buy", "tone": "neutral"}, {"label": "Price vs Trend", "value": "-", "tone": "neutral"}, {"label": "Volume", "value": "0.1x", "tone": "neutral"}], "opportunities": ["Price is above Fair Value, showing premium demand versus the model."], "risks": ["The trend backdrop is inactive, so price action has not confirmed a constructive regime.", "1 reversal markers appear in the recent smart-money tape."], "watch_points": ["Price is close to its 52-week high; watch for continuation or exhaustion.", "A volume ratio above 1.5x would show stronger participation in the next move."], "recent_rows": [{"week": "2026-07-31", "close": "28.56 USD", "return": null, "return_tone": null, "trend_line": "-", "fair_value": "27.00 USD", "activity_pressure": "-", "relative_leadership": "-", "volume": "93.3K", "trend_backdrop": null}, {"week": "2026-07-24", "close": "25.45 USD", "return": null, "return_tone": null, "trend_line": "-", "fair_value": "25.45 USD", "activity_pressure": "-", "relative_leadership": "-", "volume": "3.0M", "trend_backdrop": null}], "intelligence": {"rating": "Caution", "rating_tone": "negative", "overall_score": "37", "primary_driver": {"label": "Sentiment", "score": 52.0, "score_label": "52", "tone": "neutral", "summary": "Weighted news tone is neutral across 49 relevant articles.", "detail": "Yarrow Bioscience (VYNE) reports CDO option holdings", "metric": "52/100", "url": "/sentiment/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "available": true, "weight": 0.95}, "primary_conflict": {"label": "Indicator analysis", "score": 7.794871794871795, "score_label": "8", "tone": "negative", "summary": "Latest 12-week confirmation: trend 0/2, activity pressure 0/2, relative leadership 0/2.", "detail": "Activity pressure -; 1 reversal markers", "metric": "8/100", "url": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "available": true, "weight": 1.45}, "options_tone": "neutral", "options": null, "evidence": [{"label": "Weekly tape", "score": 40.31561053646305, "score_label": "40", "tone": "neutral", "summary": "Trend, activity pressure, participation, and risk combine to a 40/100 tape read.", "detail": "", "metric": "40/100", "url": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "available": true, "weight": 1.6}, {"label": "Indicator analysis", "score": 7.794871794871795, "score_label": "8", "tone": "negative", "summary": "Latest 12-week confirmation: trend 0/2, activity pressure 0/2, relative leadership 0/2.", "detail": "Activity pressure -; 1 reversal markers", "metric": "8/100", "url": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "available": true, "weight": 1.45}, {"label": "Factors", "score": 36.55072463768116, "score_label": "37", "tone": "negative", "summary": "O'Shaughnessy factor stack blends value, quality, momentum, and confidence.", "detail": "Buyback Yield rank 50", "metric": "37/100", "url": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "available": true, "weight": 1.2}, {"label": "Patient Capital", "score": 48.0, "score_label": "48", "tone": "neutral", "summary": "Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.", "detail": "No recent buy signal", "metric": "Quiet", "url": "/patient-capital/", "available": true, "weight": 1}, {"label": "Sentiment", "score": 52.0, "score_label": "52", "tone": "neutral", "summary": "Weighted news tone is neutral across 49 relevant articles.", "detail": "Yarrow Bioscience (VYNE) reports CDO option holdings", "metric": "52/100", "url": "/sentiment/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "available": true, "weight": 0.95}, {"label": "Insiders", "score": 44.0, "score_label": "44", "tone": "neutral", "summary": "1 acquisitions and 8 disposals in the latest 180-day insider tape.", "detail": "", "metric": "1 / 8", "url": "/insider-activity/api/?ticker=VYNE", "available": true, "weight": 0.7}, {"label": "Earnings", "score": 48.0, "score_label": "48", "tone": "neutral", "summary": "Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.", "detail": "", "metric": "12d", "url": "/earnings-calendar/", "available": true, "weight": 0.55}], "positives": [], "negatives": [{"label": "Indicator analysis", "score": 7.794871794871795, "score_label": "8", "tone": "negative", "summary": "Latest 12-week confirmation: trend 0/2, activity pressure 0/2, relative leadership 0/2.", "detail": "Activity pressure -; 1 reversal markers", "metric": "8/100", "url": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "available": true, "weight": 1.45}, {"label": "Factors", "score": 36.55072463768116, "score_label": "37", "tone": "negative", "summary": "O'Shaughnessy factor stack blends value, quality, momentum, and confidence.", "detail": "Buyback Yield rank 50", "metric": "37/100", "url": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "available": true, "weight": 1.2}], "conclusion": ["The strongest supporting evidence is sentiment: Weighted news tone is neutral across 49 relevant articles.", "The main constraint is indicator analysis: Latest 12-week confirmation: trend 0/2, activity pressure 0/2, relative leadership 0/2.", "The combined read is defensive, so risk control and evidence of stabilization matter more than headline upside."], "weekly_changes": [{"label": "Price follow-through", "value": "12.2%", "detail": "Latest completed week; four-week move -.", "tone": "positive", "url": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}, {"label": "Indicator stack", "value": "0/50", "detail": "Trend and activity pressure are weighted against the latest 12-week confirmation window.", "tone": "negative", "url": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}, {"label": "Trend backdrop", "value": "Active", "detail": "The trend backdrop defines the current weekly regime.", "tone": "positive", "url": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}, {"label": "Patient Capital", "value": "Quiet", "detail": "Activity-pressure buy-signal status for institutional accumulation timing.", "tone": "neutral", "url": "/patient-capital/"}, {"label": "News sentiment", "value": "52/100", "detail": "49 relevant articles in the latest sentiment read.", "tone": "neutral", "url": "/sentiment/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}, {"label": "Event risk", "value": "12d", "detail": "Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.", "tone": "negative", "url": "/earnings-calendar/"}]}, "investor_view": {"stance": "Mixed setup", "stance_tone": "neutral", "setup_score": "44", "bottom_line": "The weekly trend is not active. Price is - below the Trend Line and sits at 100.0% of its 52-week range. The latest completed week returned 12.2%, after a - four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 52/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal; earnings are due in 12d.", "price_summary": "The weekly trend is not active. Price is - below the Trend Line and sits at 100.0% of its 52-week range. The latest completed week returned 12.2%, after a - four-week move.", "volume_summary": "Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.", "momentum_summary": "Performance is - over four weeks, - over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.", "fundamentals": {"available": true, "summary": "The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.", "week_end": "2026-07-26", "financials_period_end": "2026-03-31", "coverage": "82%", "confidence": "78%", "url": "", "rank_scores": [{"label": "Overall factor strength", "value": "30/100", "width": 30.0, "tone": "neutral", "detail": "Blend of value, momentum, and quality. Underlying universe rank 71; rank 1 is best."}, {"label": "Value", "value": "41/100", "width": 41.0, "tone": "neutral", "detail": "Relative valuation strength. Underlying universe rank 60; rank 1 is best."}, {"label": "Quality", "value": "40/100", "width": 40.0, "tone": "neutral", "detail": "Profitability and accounting quality. Underlying universe rank 61; rank 1 is best."}, {"label": "Momentum", "value": "41/100", "width": 41.0, "tone": "neutral", "detail": "Medium-term price momentum. Underlying universe rank 60; rank 1 is best."}, {"label": "Growth", "value": "41/100", "width": 41.0, "tone": "neutral", "detail": "Revenue and earnings growth. Underlying universe rank 60; rank 1 is best."}], "groups": [{"title": "Valuation", "summary": "How much investors are paying for earnings, sales, and cash flow.", "metrics": [{"label": "P/E", "value": "-", "detail": "Price divided by trailing earnings.", "tone": "neutral"}, {"label": "Price / sales", "value": "-", "detail": "Market value relative to trailing revenue.", "tone": "neutral"}, {"label": "EV / EBITDA", "value": "-", "detail": "Enterprise value relative to operating cash earnings.", "tone": "neutral"}, {"label": "Free-cash-flow yield", "value": "-", "detail": "Free cash flow as a share of enterprise value.", "tone": "neutral"}]}, {"title": "Business quality", "summary": "Margins and the return generated on invested capital.", "metrics": [{"label": "Gross margin", "value": "98.7%", "detail": "Gross profit retained from each unit of revenue.", "tone": "neutral"}, {"label": "Operating margin", "value": "-4782.8%", "detail": "Operating profit retained from revenue.", "tone": "neutral"}, {"label": "Free-cash-flow margin", "value": "-5670.5%", "detail": "Free cash flow generated from revenue.", "tone": "neutral"}, {"label": "Return on invested capital", "value": "-52533.9%", "detail": "Operating return generated on invested capital.", "tone": "neutral"}]}, {"title": "Growth and financial strength", "summary": "Recent business growth and accounting strength.", "metrics": [{"label": "Revenue growth", "value": "-25.0%", "detail": "Latest one-year revenue growth.", "tone": "neutral"}, {"label": "EPS growth", "value": "-", "detail": "Latest one-year earnings-per-share growth.", "tone": "neutral"}, {"label": "Free-cash-flow growth", "value": "-", "detail": "Latest one-year free-cash-flow growth.", "tone": "neutral"}, {"label": "Piotroski F-score", "value": "2/9", "detail": "Nine-point accounting-strength checklist.", "tone": "neutral"}]}, {"title": "Shareholder return and balance sheet", "summary": "Cash returned to owners and financial leverage.", "metrics": [{"label": "Dividend yield", "value": "-", "detail": "Cash dividends relative to market value.", "tone": "neutral"}, {"label": "Buyback yield", "value": "-", "detail": "Net share repurchases relative to market value.", "tone": "neutral"}, {"label": "Shareholder yield", "value": "-", "detail": "Dividend yield plus net buyback yield.", "tone": "neutral"}, {"label": "Net debt / EBITDA", "value": "1.1x", "detail": "Balance-sheet debt relative to operating cash earnings.", "tone": "neutral"}]}]}, "weekly_change": [{"label": "Price follow-through", "value": "12.2%", "detail": "Latest completed week; four-week move -.", "tone": "positive", "url": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}, {"label": "Indicator stack", "value": "0/50", "detail": "Trend and activity pressure are weighted against the latest 12-week confirmation window.", "tone": "negative", "url": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}, {"label": "Trend backdrop", "value": "Active", "detail": "The trend backdrop defines the current weekly regime.", "tone": "positive", "url": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}, {"label": "Patient Capital", "value": "Quiet", "detail": "Activity-pressure buy-signal status for institutional accumulation timing.", "tone": "neutral", "url": "/patient-capital/"}, {"label": "News sentiment", "value": "52/100", "detail": "49 relevant articles in the latest sentiment read.", "tone": "neutral", "url": "/sentiment/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}, {"label": "Event risk", "value": "12d", "detail": "Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.", "tone": "negative", "url": "/earnings-calendar/"}], "strengths": ["Price is above Fair Value, showing premium demand versus the model."], "risks": ["The trend backdrop is inactive, so price action has not confirmed a constructive regime.", "1 reversal markers appear in the recent smart-money tape."], "watch_points": ["Price is close to its 52-week high; watch for continuation or exhaustion.", "A volume ratio above 1.5x would show stronger participation in the next move."], "evidence": {"weekly_tape": {"label": "Weekly tape", "score": 40.31561053646305, "score_label": "40", "tone": "neutral", "summary": "Trend, activity pressure, participation, and risk combine to a 40/100 tape read.", "detail": "", "metric": "40/100", "url": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "available": true, "weight": 1.6}, "indicator_analysis": {"label": "Indicator analysis", "score": 7.794871794871795, "score_label": "8", "tone": "negative", "summary": "Latest 12-week confirmation: trend 0/2, activity pressure 0/2, relative leadership 0/2.", "detail": "Activity pressure -; 1 reversal markers", "metric": "8/100", "url": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "available": true, "weight": 1.45}, "factors": {"label": "Factors", "score": 36.55072463768116, "score_label": "37", "tone": "negative", "summary": "O'Shaughnessy factor stack blends value, quality, momentum, and confidence.", "detail": "Buyback Yield rank 50", "metric": "37/100", "url": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "available": true, "weight": 1.2}, "patient_capital": {"label": "Patient Capital", "score": 48.0, "score_label": "48", "tone": "neutral", "summary": "Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.", "detail": "No recent buy signal", "metric": "Quiet", "url": "/patient-capital/", "available": true, "weight": 1}, "sentiment": {"label": "Sentiment", "score": 52.0, "score_label": "52", "tone": "neutral", "summary": "Weighted news tone is neutral across 49 relevant articles.", "detail": "Yarrow Bioscience (VYNE) reports CDO option holdings", "metric": "52/100", "url": "/sentiment/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "available": true, "weight": 0.95}, "insiders": {"label": "Insiders", "score": 44.0, "score_label": "44", "tone": "neutral", "summary": "1 acquisitions and 8 disposals in the latest 180-day insider tape.", "detail": "", "metric": "1 / 8", "url": "/insider-activity/api/?ticker=VYNE", "available": true, "weight": 0.7}, "earnings": {"label": "Earnings", "score": 48.0, "score_label": "48", "tone": "neutral", "summary": "Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.", "detail": "", "metric": "12d", "url": "/earnings-calendar/", "available": true, "weight": 0.55}}, "section_nav": [{"id": "overview", "label": "Overview"}, {"id": "price-action", "label": "Price"}, {"id": "volume-demand", "label": "Volume"}, {"id": "momentum", "label": "Momentum"}, {"id": "fundamentals", "label": "Fundamentals"}, {"id": "ownership-flow", "label": "Ownership & Flow"}, {"id": "catalysts-risk", "label": "Catalysts & Risk"}, {"id": "peer-context", "label": "Peer Context"}, {"id": "weekly-data", "label": "Weekly Data"}]}, "chart_url": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "api_path": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/api/"}